115 related articles for article (PubMed ID: 6694088)
1. High-performance liquid chromatographic assay for sodium levothyroxine in tablet formulations: content uniformity applications.
Garnick RL; Burt GF; Long DA; Bastian JW; Aldred JP
J Pharm Sci; 1984 Jan; 73(1):75-7. PubMed ID: 6694088
[TBL] [Abstract][Full Text] [Related]
2. Reversed-phase high-performance liquid chromatographic analysis of liothyronine sodium and levothyroxine sodium in tablet formulations: preliminary studies on dissolution and content uniformity.
Rapaka RS; Knight PW; Prasad VK
J Pharm Sci; 1981 Feb; 70(2):131-4. PubMed ID: 7205213
[TBL] [Abstract][Full Text] [Related]
3. Stability-indicating assay, dissolution, and content uniformity of sodium levothyroxine in tablets.
Richheimer SL; Amer TM
J Pharm Sci; 1983 Nov; 72(11):1349-51. PubMed ID: 6644603
[TBL] [Abstract][Full Text] [Related]
4. Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.
Shah RB; Bryant A; Collier J; Habib MJ; Khan MA
Int J Pharm; 2008 Aug; 360(1-2):77-82. PubMed ID: 18524511
[TBL] [Abstract][Full Text] [Related]
5. Determination of sodium levothyroxine in bulk, tablet, and injection formulations by high-performance liquid chromatography.
Brower JF; Toler DY; Reepmeyer JC
J Pharm Sci; 1984 Sep; 73(9):1315-7. PubMed ID: 6491963
[TBL] [Abstract][Full Text] [Related]
6. The separation and determination of liothyronine and levothyroxine in tablets by reversed-phase high performance liquid chromatography.
Smith DJ; Biesemeyer M; Yaciw C
J Chromatogr Sci; 1981 Feb; 19(2):72-8. PubMed ID: 7228964
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous assay of hydrocodone bitartrate and acetaminophen in a tablet formulation.
Wallo WE; D'Adamo A
J Pharm Sci; 1982 Oct; 71(10):1115-8. PubMed ID: 7143208
[TBL] [Abstract][Full Text] [Related]
8. Development and application of a validated HPLC method for the analysis of dissolution samples of levothyroxine sodium drug products.
Collier JW; Shah RB; Bryant AR; Habib MJ; Khan MA; Faustino PJ
J Pharm Biomed Anal; 2011 Feb; 54(3):433-8. PubMed ID: 20947276
[TBL] [Abstract][Full Text] [Related]
9. A new universal high-performance liquid chromatographic method for determination of 1,4-benzodiazepines as bulk drugs and in pharmaceutical formulations.
Kazemifard AG; Javadzadeh N; Gholami K
Acta Pol Pharm; 2008; 65(2):179-86. PubMed ID: 18666423
[TBL] [Abstract][Full Text] [Related]
10. A novel automated hydrophilic interaction liquid chromatography method using diode-array detector/electrospray ionization tandem mass spectrometry for analysis of sodium risedronate and related degradation products in pharmaceuticals.
Bertolini T; Vicentini L; Boschetti S; Andreatta P; Gatti R
J Chromatogr A; 2014 Oct; 1365():131-9. PubMed ID: 25242223
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic analysis of digoxin formulations.
Desta B; McErlane KM
J Pharm Sci; 1982 Jul; 71(7):777-80. PubMed ID: 7120061
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic determination of isoniazid and 1-isonicotinyl-2-lactosylhydrazine in isoniazid tablet formulations.
Butterfield AG; Lovering EG; Sears RW
J Pharm Sci; 1980 Feb; 69(2):222-4. PubMed ID: 7359334
[TBL] [Abstract][Full Text] [Related]
13. Simple high-performance liquid chromatographic assay for norethindrone--mestranol in combination tablets.
Sundaresan GM; Goehl TJ; Prasad VK
J Pharm Sci; 1981 Jun; 70(6):702-4. PubMed ID: 7252827
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatographic analysis of digitoxin formulations.
Desta B; McErlane KM
J Pharm Sci; 1982 Sep; 71(9):1018-20. PubMed ID: 7131266
[TBL] [Abstract][Full Text] [Related]
15. High-pressure liquid chromatographic assay of quinestrol tablets.
Tsilifonis DC; Chafetz L
J Pharm Sci; 1980 Dec; 69(12):1461-3. PubMed ID: 7463343
[TBL] [Abstract][Full Text] [Related]
16. Determination of diphenoxylate hydrochloride and atropine sulfate in combination drug formulations by liquid chromatography.
Lehr GJ
J AOAC Int; 1996; 79(6):1288-93. PubMed ID: 8946706
[TBL] [Abstract][Full Text] [Related]
17. Stability-indicating HPLC method for determination of naftazone in tablets. Application to degradation kinetics and content uniformity testing.
Walash MI; Belal F; El-Enany N; Eid M; El-Shaheny RN
J Chromatogr Sci; 2011 Aug; 49(7):495-501. PubMed ID: 21801479
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
[TBL] [Abstract][Full Text] [Related]
19. Stability-indicating high performance liquid chromatographic method for determination of norfloxacin in bulk form and tablets.
al-Deeb OA; Abdel-Moety EM; Abounassif MA; Alzaben SR
Boll Chim Farm; 1995 Oct; 134(9):497-502. PubMed ID: 8527102
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.
Emami J; Ghassami N; Ahmadi F
J Pharm Biomed Anal; 2006 Mar; 40(4):999-1005. PubMed ID: 16176866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
